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Abstract
Background: Reproductive history, particularly maternal age at most recent birth, may reflect lower risk for
chronic disease and mortality due to socioeconomic factors, lifestyle behaviors, or genetics. Reproductive
history has not been examined with respect to hepatic steatosis, the most common liver disease in the United
States. Our objective was to examine the association between reproductive history and hepatic steatosis.
Methods: We examined the association between reproductive history characteristics—specifically age at most
recent birth—and the odds of moderate to severe hepatic steatosis using a population-based retrospective cohort
study of women who underwent hepatic ultrasound at the Michigan site of the Study of Women’s Health Across
the Nation (n = 331).
Results: Women who gave birth at ‡ 35 years of age comprised 19% of the study population and were similar
to other women regarding sociodemographic history and health behaviors. In multivariable analyses adjusting
for age, race/ethnicity, chronic disease, and medications associated with hepatic steatosis, age at birth ‡ 35
years was associated with significantly decreased odds of hepatic steatosis (adjusted odds ratio [OR] 0.41, 95%
confidence interval [CI] 0.20–0.87), which was attenuated after adjustment for waist circumference (OR 0.51,
95% CI 0.24–1.10). Other reproductive factors including gravidity, parity, miscarriages and abortions, recall of
gestational weight gain, breastfeeding, age at first birth, and age at final menstrual period were not associated
with hepatic steatosis.
Conclusions:Women who were older at their most recent birth had a reduced odds of hepatic steatosis, possibly
associated with their lower waist circumference.
Introduction
Nonalcoholic hepatic steatosis, also known as fattyliver disease, is the most common liver disease in the
United States1 and may account for one-third of newly di-
agnosed chronic liver disease.2 Hepatic steatosis is a pre-
cursor to liver inflammation and cirrhosis3 and also may be a
risk factor for diabetes, poorer glycemic control among adults
with diabetes, impaired renal function, and cardiovascular
events.4 In one population-based report, hepatic steatosis
affected one-quarter of non-Hispanic white and African
American women who were approximately 45 years of age.5
Risk factors include metabolic syndrome and associated
conditions such as polycystic ovarian syndrome (PCOS)6,
menopause,7 and sex hormone levels,8 as well as specific
polymorphisms such as patatin-like phospholipase domain-
containing protein 3 (PNPLA3).4 We have previously re-
ported that hepatic steatosis affected postmenopausal non-
Hispanic white women more often than African American
women and was associated with greater waist circumference,
an adverse lipid profile, and hypoglycemic medication use, as
well as sex hormone binding globulin (SHBG).9 Therefore, it
is important to identify risk factors for hepatic steatosis,
particularly those that occur before midlife.
One set of potential risk factors is reproductive history, in-
cluding factors such as maternal age at birth, gravidity, and
parity. Although these factors are straightforward to ascertain
and occur prior to the peak prevalence of liver disease, they
have not been examined with respect to future chronic liver
disease. In particular, women’s age at their most recent preg-
nancy might be particularly relevant for future chronic disease
risk. Multiple studies have observed an association between
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older maternal age and exceptional longevity.10–13 While the
mechanisms are speculative, behavior and genetics predis-
posing to longer life may also prolong the reproductive period.
The disposable soma theory states that there is a tradeoff in
energy allocation between reproductive fitness and repair, so
that women who maintain fertility are able to do so because
they need to devote less energy to maintenance of other organ
systems.14,15 Perls and Fretts have hypothesized that longevity
associated genetic variants predisposing to longevity could
also facilitate a longer period of childbearing.11
Maternal age at most recent birth reflects women’s ovarian
health or ovarian ‘‘reserve,’’16 as well as socioeconomic
factors, cultural choices, and partner health. In one cohort
study, primiparous mothers with a birth ‡ 35 years of age
(i.e., ‘‘advanced maternal age’’) were more educated, more
likely to be employed, and of higher socioeconomic status
than women who were not of advanced maternal age.17
Some, but not all, of these women had experienced fertility
difficulties. 17 Thus, women who have a later age at childbirth
may have delayed childbearing in order to optimize educa-
tional and professional opportunities. These socioeconomic
advantages may translate into improved lifestyle behaviors,
with lower risk for obesity and subsequent chronic disease,18
and thus greater age at most recent birth can reflect these
upstream socioeconomic factors. However, women who have
a later age at childbirth may also have impaired fertility,
which could translate into greater chronic disease risk. To our
knowledge, the relationship between later-life pregnancy and
chronic disease such as hepatic steatosis has not previously
been examined.
The Study ofWomen’s Health Across the Nation (SWAN)
is an ongoing population-based cohort study designed to
characterize biological and symptomatic changes that occur
during and after menopause among women of different racial/
ethnic backgrounds.19 Data collected included a retrospective
reproductive history including age at the most recent preg-
nancy. The Michigan SWAN site ascertained the presence of
hepatic steatosis with ultrasound at the 2010 follow-up visit.
Thus, we were able to assess the relationship between age at
most recent birth from women’s reproductive years with the
presence of postmenopausal hepatic steatosis. We hypothe-
sized that greater age at most recent birth would be associated
with lower odds of hepatic steatosis, and this associationwould
be reduced after adjustment for anthropometrics.
Materials and Methods
Study population
The Study ofWomen’s Health Across the Nation (SWAN)
is a community-based cohort study conducted at seven sites
in the United States. The sample for the current report was
drawn from the Michigan site of the SWAN cohort. Re-
cruitment procedures and the study design used for SWAN
have been described elsewhere.19–21 Briefly, in 1996–1997,
women aged 40–55 years were screened from defined sam-
pling frames at seven clinical sites throughout the United
States. Eligible women were invited to participate in a lon-
gitudinal study of the natural history of the menopausal
transition. To be eligible, women had to be between 42 and 52
years of age, have an intact uterus and at least one ovary,
report having had a menstrual period in the previous 3
months, not report estrogen therapy in the 3 months prior to
recruitment, and not currently be pregnant or breast-feeding.
The Michigan site recruited women who self-identified as
African-American or white. The cohort participated in a
baseline clinical examination and continues to participate in
follow-up examinations. All participants gave informed
consent, and all study procedures were approved by the
University of Michigan institutional review board.
All women at the Michigan site were invited to undergo
hepatic ultrasound at the time of their 2010 follow-up visit.
At that visit, 345 (85%) of the 406 Michigan SWAN women
who participated underwent hepatic ultrasound. Women who
did and did not undergo ultrasounds were similar with respect
to demographic characteristics, alcohol and medication use,
and anthropometric characteristics. Of the women with he-
patic ultrasound measures, 14 women reported a history of
cirrhosis or chronic liver disease due to viral hepatitis or
hemachromatosis, and were excluded, leaving a total analytic
sample of 331 participants for this report.
Data collection
The SWAN protocol includes annual ascertainment about
menstrual status, reproductive events, socioeconomic status,
history of diabetes, liver disease, alcohol and medication use
from questionnaires, anthropometrics, blood pressure as-
sessments, and serum measures. Data from the 2010 annual
visit was used for this analysis. Reproductive history was
assessed at the baseline visit; women were asked about the
number of pregnancies, live births, miscarriages and abor-
tions, weight gain with each pregnancy, and length of
breastfeeding with each delivery, as well as maternal age at
each delivery. Distributions of each variable were examined
and categorized as described in Table 1. Women were cate-
gorized as having given birth at 35 years of age or older or
not, based on classifications of increased infertility risk.16
Forty-six women reported not having had a live birth, in-
cluding 30 nulligravidas, and were characterized as not
having a birth at ‡ 35 years of age.
Age at cessation of menses was based on the age at the last
menstrual period. Alcohol intake was categorized as less than
1 drink per day versus > 1 drink per day; only 12 women had
2 or more drinks per day. Information regarding use of
medications reported to influence hepatic steatosis (including
metformin, thiazolidinediones, orlistat, or sibutramine) was
obtained, as was exogenous estrogen therapy. As part of
study enrollment, no women used exogenous sex hormone
therapy at baseline, but at the time of ultrasound, 28 women
used exogenous estrogen therapy and 7 used progesterone
therapy. No women used sibutramine, and only one woman
used Orlistat. Weight and height, measured by use of cali-
brated scales and a stadiometer, were used to calculate body
mass index (BMI) (kg/m2). Waist circumference was mea-
sured to the nearest 0.1 cm with a measuring tape placed
horizontally around the participant at the narrowest part of
the torso.
All abdominal ultrasounds were performed by a single
ultrasound technician unaware of the clinical and laboratory
results of the participants on a Sonoline Elegra Ultrasound
Imaging System (Siemens Medical Systems Inc.) using a
3.5MHz transducer, a phantom (411 LE 0.5, GAMMEX rmi
Ltd.,) and were also read by a radiologist who was blinded to
participant profile. Ultrasound studies were performed and
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classified according to the protocol of the Edinburgh Type 2
Diabetes Study22 and these procedures have been previously
reported for the SWAN cohort.9 For the purposes of this
analysis, hepatic steatosis was characterized as moderate/
severe or none.
Statistical analyses
First, we examined demographics, reproductive history,
and body mass index and waist circumference by age at the
most recent birth using t-tests for continuous variables and
Table 1. Baseline Characteristics of Women by Maternal Age at Most Recent Birth,
Given as Mean (Standard Deviation) or Percentage
No birth at age ‡ 35 years Age ‡ 35 years
N = 269 N= 62 p value
Age, years 45.8 (2.8) 45.1 (2.5) 0.09
Race/ethnicity 0.18
Non-Hispanic white 38% 47%
African American 62% 53%
Education level 0.51
Less than high school 7% 3%
High school 23% 15%
More than high school, but less than college 46% 53%
College 13% 15%
More than college 11% 14%
Difficulty paying for basics (from year 12) 0.20
Very hard 12% 13%
Somewhat hard 32% 44%
Not very hard at all 56% 44%
Behaviors and Medications
Alcohol use
< 1 drink per day at year 12 64% 66% 0.78
‡ 1 drink per day at year 12 36% 34%
Smoker, at year 12 17% 16% 0.80
Diabetes at baseline 8% 2% 0.10
Metformin and thiazolidinediones at year 12 16% 13% 0.50
Estrogen use, ever 39% 40% 0.89
Reproductive history
Ever had difficulty getting pregnant 20% 39% 0.002
Age at first menses, years 12.1 (3.4) 12.5 (1.8) 0.18
Age at first birth, years 20.7 (4.0) 25.9 (7.0) <0.01
Age at most recent birth, years 26.8 (4.3) 37.6 (2.3) <0.01
Gravidity, mean 3.0 (2.1) 4.6 (2.5) <0.01
Parity, mean 2.7 (1.2) 3.4 (1.9) <0.01
Any breastfeeding 32% 66% <0.01
Age at final menstrual period, yearsa 51.4 (4.6) (n = 174) 51.8 (3.1) (n = 37) 0.51
Anthropometric characteristics
Body mass index category at baseline 0.04
< 25 kg/m2 22% 36%
25–29.9 kg/m2 27% 30%
‡ 30 kg/m2 51% 34%
Body mass index category at year 12 0.14
< 25 kg/m2 12% 15%
25–29.9 kg/m2 22% 32%
‡ 30 kg/m2 66% 53%
Change in body mass index from baseline to year 12 4.0 (10.5) 4.0 (4.8) 0.95
Waist circumference (cm) at baseline, cm 95.0 (16.5) 90.1 (14.7) 0.03
Waist circumference (cm) at year 12, cm 101.9 (17.6) 98.0 (15.9) 0.11
Hip circumference (cm) at baseline, cm 114.7 (15.9) 110.1 (13.0) 0.02
Hip circumference (cm) at year 12, cm 117.8 (17.5) 113.5 (15.9) 0.08
Cumulative weight gain with pregnancies, kgb 37.0 (21.9) 52.7 (37.7) 0.003
Quartile of weight gain with pregnancy, < 0.01
Quartile 1: < 20.4 kg 35% 18%
Quartile 2: 20.4–33.5 kg 23% 21%
Quartile 3: 33.6–54.5 kg 24% 16%
Quartile 4: > 54.5 kg 17% 45%
aIn the Study of Women’s Health Across the Nation, only calculated for women who underwent natural menopause.
bExcludes women without a pregnancy.
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chi-squared tests for categorical variables; Wilcoxon tests
were used for comparison of variables with skewed distri-
butions (Table 1). In a previous report, we noted that risk
factors for hepatic steatosis in optimally fitting models in-
cluded waist circumference, high-density lipoprotein cho-
lesterol levels, SHBG levels, alcohol use, medication use, and
race/ethnicity.9 Waist circumference and markers of visceral
adiposity, rather than BMI, was more strongly correlated with
hepatic steatosis in that report as well as in other studies. 23–25
For the present report, we also compared the metabolic
characteristics of women who had and had not given birth at
or after 35 years of age by race/ethnicity (Table 2).
Next, we created multivariable logistic regression models
that examined the association between age at most recent
birth (continuous and using the cutpoint of 35 years) and
hepatic steatosis, before and after adjustment for covariates
associated with steatosis in bivariate analyses (i.e., age, race/
ethnicity, alcohol use, and use of medications previously
reported to influence hepatic steatosis) (Table 3).9 As other
metabolic variables were not associated with both age at most
recent birth and hepatic steatosis in the prior report, these
were not included in the models. To determine whether as-
sociations between reproductive history variables and hepatic
steatosis were mediated or confounded by adiposity, we
created models that further adjusted for waist circumference
at baseline. We also created models that included an inter-
action term between race/ethnicity and reproductive history
variables as well as models that stratified by race/ethnicity, as
previous reports have noted racial/ethnic differences in he-
patic steatosis;9 however, interaction terms were not signifi-
cant and a similar pattern of effects was noted within race/
ethnicity. All analyses were conducted using SAS version 9.3
(SAS Institute).
Results
Table 1 shows the characteristics among women by whe-
ther or not they gave birth at‡ 35 years of age. Women who
gave birth at‡ 35 years of age comprised 19% of the study
population. These women were similar to women who did not
give birth after 35 years of age regarding their age at en-
rollment, education level, and difficulty paying for basics,
patterns of alcohol use, cigarette smoking, diabetes, and hy-
poglycemic medication use. Metformin was used in women
with diagnosed diabetes. Women who gave birth at the
age ‡ 35 years were older at the age of first birth as well as
recent birth but were pregnant more often, had a greater
number of deliveries, and were more likely to breastfeed than
parous women who were younger at most recent birth. Wo-
men who gave birth at the age ‡ 35 years were more likely to
report difficulty conceiving than women who had not given
birth at advanced maternal age. Women had a similar age of
menopause regardless of age at last birth. Over the approxi-
mately 12-year period, both women who gave birth at or after
the age of 35 years and women who did not gained a sig-
nificant amount of weight, as represented in their increase in
Table 2. Metabolic Characteristics of Women Who Gave Birth
at or After the Age of 35 Years Compared with Those Who Did Not
No birth at
‡ 35 years ‡ 35 years
No birth at
‡ 35 years > 35 years
Non-Hispanic white women African-American women
N = 101 N= 29 p value N = 168 N= 33 p value
Waist circumference (cm) 102.3 (17.5) 97.7 (18.1) 0.21 101.6 (17.8) 98.3 (14.1) 0.31
Fasting glucose (mg/dL) 112.9 (66.5) 98.3 (29.2) 0.10 102.3 (38.0) 105.2 (45.9) 0.70
Fasting insulin (IU/L)a 18.1 (21.3) 11.8 (10.7) 0.06 18.5 (25.5) 15.0 (11.7) 0.82
Triglycerides (mg/dL)a 136.6 (32.5) 140.7 (64.1) 0.40 111.8 (56.5) 108.2 (43.5) 0.93
High-density lipoprotein (mg/dL) 57.3 (15.0) 57.9 (15.6) 0.86 55.5 (16.1) 56.7 (18.1) 0.71
Low-density lipoprotein (mg/dL) 118.0 (32.3) 138.3 (40.9) < 0.01 113.6 (35.3) 117.5 (36.5) 0.57
Systolic blood pressure (mmHg) 123.4 (16.0) 125.6 (23.1) 0.62 133.7 (19.4) 133.1 (20.0) 0.86
Diastolic blood pressure (mmHg) 70.3 (9.0) 71.7 (9.6) 0.48 75.0 (10.8) 78.0 (10.7) 0.15
Sex hormone binding globulin (nM/L) 56.7 (30.3) 56.4 (28.3) 0.96 55.1 (32.1) 57.6 (31.8) 0.69
aWilcoxon rank-sum tests used.
Table 3. Unadjusted and Adjusted Odds Ratios of Hepatic Steatosis
by Maternal Age at Most Recent Birth
Unadjusted OR [95% CI] Adjusted ORa [95% CI] Adjusted ORb [95% CI]
Age at most recent birth (continuous,
years)
0.95 [0.91–0.998] 0.95 [0.91–0.998] 0.95 [0.91–1.001]
Age at most recent birth ‡ 35 years
(reference is age at most recent birth
< 35 years)
0.42 [0.20–0.87] 0.41 [0.20–0.87] 0.51 [0.24–1.10]
aAdjusts for age, race/ethnicity, alcohol use ( < 1 drink per day vs. ‡ 1 drink per day), and use of medications for diabetes.
bAdjusts for factors above and waist circumference at baseline.
CI, confidence interval; OR, odds ratio.
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BMI ( p< 0.001 from baseline), although this gain did not
differ by recency of last birth (Table 1). Finally, anthropo-
metric characteristics were similar between the two groups of
women except that women who gave birth at ‡ 35 years had a
BMI that was slightly lower at baseline and a significantly
lower waist and hip circumference at baseline; anthropo-
metric characteristics at the year of ultrasound did not differ
significantly. Women who gave birth at age ‡ 35 years had
greater cumulative weight gain with pregnancy.
In analyses stratified by race/ethnicity, women who had
given birth at or after 35 years of age had a similar metabolic
profile compared to women who had not (Table 2), except
among non-Hispanic white women, low-density lipoprotein
cholesterol was higher among women who had given birth
more recently compared with women who had not. Fasting
glucose and insulin levels were slightly, but not significantly,
lower among women who had given birth at or after 35 years
among white women.
Table 3 shows the odds of steatosis associated with char-
acteristics of reproductive history. In unadjusted analyses,
greater age at most recent birth was associated with a lower
odds of hepatic steatosis when age was examined as a con-
tinuous variable as well as ‡ 35 years or < 35 years. After
adjustment for other risk factors for hepatic steatosis, the
association persisted. After further adjustment for baseline
waist circumference, the association was attenuated and of
borderline statistical significance.
We conducted a series of sensitivity analyses to determine
if the relationships between age ‡ 35 years at the most recent
birth and steatosis were altered by socioeconomic variables
or other aspects of the reproductive history. In bivariate
comparisons, education level, difficulty for paying for basics,
gravidity (continuously measured), parity (continuously
measured), nulligravidity (yes/no), nulliparity (yes/no), and
grand multiparity ( > 5 births) were not associated with he-
patic steatosis. Breastfeeding was not associated with hepatic
steatosis when categorized as none versus any ( p = 0.18) or as
none, some, or any breastfeeding ( p = 0.39). Cumulative
weight gain with pregnancies and quartile of pregnancy
weight gain were also not associated with hepatic steatosis in
bivariate comparisons ( p > 0.20 for both associations). In
multivariable models including age at most recent pregnancy,
additional adjustment for education, difficulty paying for
basic needs, breastfeeding, cumulative weight gain during
pregnancy, or BMI did not significantly alter the observed
relationship. The association between age at most recent birth
and steatosis was attenuated after the adjustment for age at
the final menstrual period, although a significant number of
women dropped out of the model due to the calculation of age
at final menstrual period only for women who underwent
natural menopause.
Discussion
We found that in a community-based, biracial cohort,
women’s reproductive history—specifically age at most re-
cent birth—was associated with a lower odds of hepatic
steatosis. This association was attenuated with adjustment for
premenopausal waist circumference. To our knowledge, our
findings are novel: other studies have not examined associ-
ations between reproductive history in general or age at most
recent birth specifically and hepatic steatosis.
Greater age at most recent birth could have been associated
with lower odds of hepatic steatosis for several reasons.
Women with later births may be more socioeconomically
advantaged with subsequently improved lifestyle behaviors
and chronic disease risk. Although we observed that the re-
lationship between age at most recent birth and steatosis
persisted after adjustment for education and difficulty paying
for basics, these measures may not have captured all aspects
of socioeconomic status, including partner status.
Second, age at most recent birth is a potential marker for
greater ovarian reserve, which can be clinically expressed as
greater fecundity in reproductive-aged women or later age at
menopause in older women. This greater reserve may have
had favorable effects upon future hepatic steatosis. However,
women who had a greater age at most recent birth actually
reported greater difficulty with conception, suggesting that
women with advanced maternal age at most recent birth did
not necessarily have greater reserve.
Third, age at most recent birth was associated with de-
creased waist circumference. Adjustment for waist circum-
ference attenuated the association between age at most recent
birth and hepatic steatosis, suggesting that adiposity played a
key role. Adiposity may reflect upstream factors, such as
socioeconomic status translating to healthier lifestyle be-
haviors. Adiposity may also reflect ovarian health. In women,
obesity may suppress ovulation and interfere with conception
and implantation either due to PCOS26 or irregular bleeding
associated with excess body mass.27 Similarly, in the Danish
National Birth Cohort, there was a dose-response relationship
between increasing BMI group and subfecundity, expressed
as a time to pregnancy of greater than 12 months.28 In rats,
caloric restriction may suppress transition from primordial to
developing follicles,29 and, if extrapolated to humans, wo-
men with lower body weights may also have preservation of
reserve.
Adjustment for age at final menstrual period attenuated the
association between hepatic steatosis and age at most recent
birth. However, age at the final menstrual period was similar
in women who gave birth and who did not give birth at ‡ 35
years. Age at most recent birth may have had significant
associations with steatosis while age at the final menstrual
period did not, because women who underwent surgical
menopause or were using hormones do not have a final
menstrual period, and we may have been underpowered to
assess a significant association.
We did not find relationships between other aspects of
reproductive history and hepatic steatosis. Pregnancy is a risk
factor for increased weight gain and abdominal girth,30,31
although how much weight is retained varies widely between
women.32 Previous studies suggest that weight gained in
pregnancy and retained after pregnancy includes fat as op-
posed to lean mass.33–36 We did not find a direct association
between cumulative pregnancy weight gain and hepatic
steatosis, or number of pregnancies and hepatic steatosis,
because pregnancy may not lead to significant accumulations
of fat in the liver, even as it leads to increased fat mass and
visceral fat deposition. Alternatively, it is possible that the
associations between pregnancy and increases in hepatic
steatosis during the reproductive years are attenuated as wo-
men age; in Michigan SWAN, hepatic steatosis was ascer-
tained approximately 8 years after the menopausal transition.
We also did not find relationships between breastfeeding and
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hepatic steatosis, again, perhaps due to the time frame that we
ascertained hepatic steatosis, or perhaps because breastfeeding
does not affect hepatic fat deposition.
The strengths of this study include its population-based
nature and longitudinal assessments of women from the
perimenopause up to a decade into postmenopause. An ad-
ditional strength is its use of women’s reproductive history as
an indicator of future chronic disease risk, and in particular,
examination of maternal age at most recent birth and chronic
liver disease. Limitations include the retrospective nature of
the reproductive history data. While women most likely re-
call accurately their age at their most recent birth and number
of pregnancies and deliveries, recall of cumulative weight
gain weight gain with pregnancy may be subject to biases in
recall. Retrospective assessment may have led to attenuation
between cumulative pregnancy weight gain and hepatic
steatosis. Another limitation is that while we speculate that
age at last pregnancy may reflect ovarian reserve, we lack
more precise markers that would lend insight into the
mechanisms that could affect the deposition of liver fat. Such
biologic markers, particularly anti-Mu¨llerian hormone, have
recently been reported in population-based studies and offer a
promising tool for prediction of age at menopause as well as
for chronic disease.37
Additional measures of liver function such as transami-
nases and viral titers were not obtained. Such information
would determine whether the hepatic steatosis on ultrasound
was also associated with inflammation, i.e. steatohepatitis,
and the etiology. PCOS has been associated with both sub-
fertility and metabolic syndrome,38 a correlate of hepatic
steatosis. Although women with PCOS were less likely to be
included in the SWAN cohort due to the study inclusion
criteria, it is possible that age at most recent birth and hepatic
steatosis are associated by their relationship to PCOS.
Conclusions
In conclusion, we found that women’s reproductive his-
tory, and particularly age at most recent birth, was associated
with decreased odds of hepatic steatosis. Prospective studies
are needed to reproduce these observations and to explore the
associations between other markers of ovarian reserve, in-
cluding biochemical markers, and hepatic steatosis. The role
of reproductive history in other racial/ethnic groups at high
risk of hepatic stenosis should be examined. As maternal age
increases and the prevalence of chronic liver disease in-
creases, it is important to understand whether the relationship
between these reflects other risk factors or causality.
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